ARS Pharmaceuticals, Inc. (SPRY)
4.56
+0.20
(+4.59%)
USD |
NASDAQ |
Oct 08, 16:00
4.64
+0.08
(+1.75%)
After-Hours: 20:00
ARS Pharmaceuticals Market Cap : 453.44M for Oct. 8, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 08, 2026 | 453.44M |
| October 07, 2026 | 433.55M |
| October 06, 2026 | 427.09M |
| October 05, 2026 | 426.59M |
| October 02, 2026 | 404.71M |
| October 01, 2026 | 409.68M |
| September 30, 2026 | 428.58M |
| September 29, 2026 | 437.53M |
| September 28, 2026 | 410.68M |
| September 25, 2026 | 405.71M |
| September 24, 2026 | 412.67M |
| September 23, 2026 | 415.65M |
| September 22, 2026 | 445.48M |
| September 21, 2026 | 432.55M |
| September 18, 2026 | 408.69M |
| September 17, 2026 | 412.67M |
| September 16, 2026 | 414.16M |
| September 15, 2026 | 422.61M |
| September 14, 2026 | 447.47M |
| September 11, 2026 | 473.32M |
| September 10, 2026 | 503.16M |
| September 09, 2026 | 520.06M |
| September 08, 2026 | 535.97M |
| September 04, 2026 | 558.84M |
| September 03, 2026 | 563.81M |
| Date | Value |
|---|---|
| September 02, 2026 | 578.73M |
| September 01, 2026 | 573.76M |
| August 31, 2026 | 596.63M |
| August 28, 2026 | 585.69M |
| August 27, 2026 | 599.61M |
| August 26, 2026 | 599.61M |
| August 25, 2026 | 568.78M |
| August 24, 2026 | 531.99M |
| August 21, 2026 | 547.41M |
| August 20, 2026 | 547.41M |
| August 19, 2026 | 634.41M |
| August 18, 2026 | 626.46M |
| August 17, 2026 | 620.49M |
| August 14, 2026 | 561.82M |
| August 13, 2026 | 606.57M |
| August 12, 2026 | 601.60M |
| August 11, 2026 | 591.66M |
| August 10, 2026 | 586.86M |
| August 07, 2026 | 611.69M |
| August 06, 2026 | 551.12M |
| August 05, 2026 | 532.25M |
| August 04, 2026 | 528.28M |
| August 03, 2026 | 542.18M |
| July 31, 2026 | 509.41M |
| July 30, 2026 | 559.06M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Capricor Therapeutics, Inc. | 465.45M |
| Sionna Therapeutics, Inc. | 221.30M |
| Nektar Therapeutics | 1.392B |
| Vertex Pharmaceuticals, Inc. | 127.50B |
| Ardelyx, Inc. | 814.71M |
Market Cap Related Metrics
| PS Ratio | 3.866 |
| PEG Ratio | -0.0061 |
| Price to Book Value | 36.24 |
| Price | 4.56 |
| Earnings Yield | -47.66% |
| PEGY Ratio | -0.0061 |